Expression of inducible nitric oxide synthase, p53 and bcl-2 in gastric precancerous and cancerous lesions: Correlation with clinical features

[1]  A. Adjei,et al.  Targeting Apoptosis Pathways in Cancer Therapy , 2005, CA: a cancer journal for clinicians.

[2]  M. Lai,et al.  Hepatitis C Virus Infection Activates the Immunologic (Type II) Isoform of Nitric Oxide Synthase and Thereby Enhances DNA Damage and Mutations of Cellular Genes , 2004, Journal of Virology.

[3]  Tomohiro Sawa,et al.  Chemical basis of inflammation-induced carcinogenesis. , 2003, Archives of biochemistry and biophysics.

[4]  H. Esumi,et al.  Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein , 2003, Acta Neuropathologica.

[5]  P. Gong,et al.  Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer. , 2002, World journal of gastroenterology.

[6]  R. Bing,et al.  Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  C. Suschek,et al.  Nitric Oxide Fully Protects against UVA-induced Apoptosis in Tight Correlation with Bcl-2 Up-regulation* , 1999, The Journal of Biological Chemistry.

[8]  W P Bennett,et al.  Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. , 1999, Journal of the National Cancer Institute.

[9]  H. Kolb,et al.  Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? , 1998, Immunology today.

[10]  John Calvin Reed.  Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. , 1997, Seminars in hematology.

[11]  H. Hartung,et al.  Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. , 1997, Cellular immunology.

[12]  C. Harris,et al.  Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  K. Kröncke,et al.  Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where? , 1997, Nitric oxide : biology and chemistry.

[14]  B. Brüne,et al.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. , 1996, The Biochemical journal.

[15]  C. Harris,et al.  Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Hartung,et al.  H2O2 and Nitric Oxide‐mediated Oxidative Stress Induce Apoptosis in Rat Skeletal Muscle Myoblasts , 1996, Journal of neuropathology and experimental neurology.

[17]  Jun-yan Hong,et al.  Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric‐cardia carcinogenesis , 1994, International journal of cancer.

[18]  S. Snyder,et al.  Nitric oxide: a neural messenger. , 1995, Annual review of cell and developmental biology.